Effect mechanism of the designed virus on cancer cells and how the immune system is called to control breast cancer.

Control of an advanced type of leukemia in the United States by a designer anticancer measles virus

A clinical study of treatment of glioblastoma with an anti-cancer virus in Spain, carried out in collaboration with the United States.
Also, we have started a clinical study of glioblastoma treatment with anti-cancer virus in Tehran hospital

The experience of treatment of advanced brain tumor in Houston hospital, USA by oncolytic virus

Treatment of cancer with an anticancer virus at Duke Hospital in the United States

What was the fate of the first recipient of the malignant brain tumor vaccine

An Australian oncologist successfully treated his own malignant brain tumor using immunotherapy. It was expected that the renowned professor—like other patients—would survive for only one year, but the latest MRI scans show that the tumor has completely disappeared.

A strategy to overcome the impasse in cancer treatment

Shortly after encountering cancer cells, the immune system becomes impaired and loses its ability to control the cancer.
We have engineered the capacity to control cancer by specifically activating the immune system.

A scientist treated her own breast cancer by injecting a vaccine she had developed herself.
The Serbian researcher was diagnosed with advanced breast cancer in 2016, and doctors had to remove her breast. In 2020, she discovered that the malignant cancer had returned.
Working with doctors, she injected an anti-cancer vaccine—which she had designed in the laboratory—directly into the breast tumor.
The treatment was successful, and she has now been cancer-free for five years.
Vaxogen.ir

The future of cancer treatment is bright;
because our science advances one step further every day.
Vaxogen.ir

The world's first treatment for esophageal cancer using a smart virus has been launched in the Japanese market.
This drug is prescribed for patients who are resistant to conventional treatments.
The cost of the drug in Japan is $58,500 per patient.
In step with developed nations, clinical trials for an anti-cancer vaccine to treat malignant tumors are currently underway in Iran.
Vaxogen.ir

Europe's largest cancer center, located in Germany,
is pursuing the treatment of malignant brain tumors using a smart virus.
In parallel with these advancements, clinical trials for an anti-cancer vaccine to treat malignant tumors are underway in Iran.
Vaxogen.ir